| Dear Member, You were just one step away from joining the Deal Hunters Alliance, but you didn't confirm your membership. I'm reaching out to let you know that we're still holding your spot in line. But I can't hold it much longer. The deadline to secure Instant Access to this historic Alpha Round deal is December 8. In the past, these deals have been filled in as little as one day, or even just a couple hours. And once it fills up, all over. New investors will be barred from getting in. So, getting in early is critical. Remember these important facts: Fact #1. Peptide-focused opportunities have already produced astonishing gains for pre-IPO investors, like 11,955% with Rhythm Pharmaceuticals and 37,989% with Protagonist Therapeutics. Fact #2. This company's technology is already making waves … and it could disrupt three global health markets worth a combined $706 BILLION … Their eye disease treatment is modelled on a peptide that is up to 8,500 times cheaper than conventional treatments … They could dominate the sleep aid market (worth over $90 billion alone) with their proprietary peptide treatment … And now their tech could radically transform a global anti-aging market valued at over $600 billion … With technology that is safer, more natural and more effective than any competing product … And patents forming a powerful moat against competitors, and protecting future profits, now through 2046. Fact #3. This Alpha Round company's leadership has a proven track record of success. They have more than 150 combined years of experience founding, leading and growing biotech companies, with multiple successful acquisitions and IPOs under their belts. Their CEO founded a biotech startup that attracted $70 million in their initial funding rounds, then landed a partnership with Novartis for $1.3 billion. After that, he founded another startup that was acquired by a pharmaceutical firm that went public in 2021 in a $2 billion IPO (4th largest in history for this industry). With decades of combined experience … hundreds of millions of dollars in successful IPOs, acquisitions and exits under their belts … and now, some of the most advanced peptide-modelled technology of its kind on their side, this new Alpha Round deal looks to be their biggest success yet. Remember: opportunities like this are normally reserved for only the most well-connected Silicon Valley insiders … But now, you have the chance to claim a seat at the table with the earliest investors … provided you don't delay any further. Right now, you have three options: - You can get a full recap of this deal and everything else that's waiting for you inside the Deal Hunters Alliance on this page.
- You can call me or my Member Care Team at 855-278-9191. We're here Monday through Friday, 9:00 a.m. - 5:30 p.m. Eastern. We'll be happy to walk you through all the details of this special offer, answer your questions and get you instant access.
- You can use this link to book a time to have one of our Member Care Team representatives call you.
But we can't hold your spot for long. This Alpha Round Pre-IPO deal is NOW OPEN and filling up fast! Your best bet: Go here right now or as soon as you can. Best wishes, Amber Martin, Director
Weiss Ratings Member Care Team | 
Tidak ada komentar:
Posting Komentar